RIPE-KG · Version 1.1.0 · Resource
ripekg:work/10.1016%2Fj.ophtha.2024.01.007
https://w3id.org/ripe/ripe-kg/work/10.1016%2Fj.ophtha.2024.01.007
| Subject | Predicate | Object |
|---|---|---|
ripekg:publication-details/RIPEA07C7CD7A66B0506AEvaluating Primary Treatment for People with Advanced Glaucoma |
ripe:concerns |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
ripekg:registry-evidence/RIPEA07C7CD7A66B0506A |
ripe:concerns |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
ripekg:research-integrity-assessment/RIPEA07C7CD7A66B0506A |
ripe:assesses |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
ripekg:study-design-evidence/RIPEA07C7CD7A66B0506A |
ripe:concerns |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
prism:doi |
10.1016/j.ophtha.2024.01.007 |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
dcterms:creator |
ripekg:author/RIPEAU08CA7390840E55A5Shahiba Begum |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
dcterms:creator |
ripekg:author/RIPEAU095AAA3C5BB728FDHosein Shabaninejad |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
dcterms:creator |
ripekg:author/RIPEAU0DB500C2DBBE1864Tim Manners |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
dcterms:creator |
ripekg:author/RIPEAU0F4B22296FBDCAF2Augusto Azuara-Blanco |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
dcterms:creator |
ripekg:author/RIPEAU1237FD19E6F67909Joanna Tryfinopoulou |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
dcterms:creator |
ripekg:author/RIPEAU146F2F520DC3B79AShenton Chew |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
dcterms:creator |
ripekg:author/RIPEAU14790D779A75BBB3Alan Rotchford |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
dcterms:creator |
ripekg:author/RIPEAU191330FC22F8DFDESimon Rankin |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
dcterms:creator |
ripekg:author/RIPEAU1B16D02B938C8E34James Kirwan |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
dcterms:creator |
ripekg:author/RIPEAU1B9850E4CA4BE4F6Luke Vale |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
dcterms:creator |
ripekg:author/RIPEAU1D406EAB2A46D0AEAtul Bansal |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
dcterms:creator |
ripekg:author/RIPEAU20383F19D95EF3F8Saurabh Goyal |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
dcterms:creator |
ripekg:author/RIPEAU2538DC8A0F8C540ENitin Anand |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
dcterms:creator |
ripekg:author/RIPEAU27D6330C195F1667Subhanjan Mukherji |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
dcterms:creator |
ripekg:author/RIPEAU2A0BDA2ADC99BAE5Ejaz Ansari |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
dcterms:creator |
ripekg:author/RIPEAU2D7D6DBAC4F4892CDuya Penmol |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
dcterms:creator |
ripekg:author/RIPEAU2EFFF41D90872EE9Roshini Sanders |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
dcterms:creator |
ripekg:author/RIPEAU2FAE3A1B9EFAB9FCJennifer Burr |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
dcterms:creator |
ripekg:author/RIPEAU32D8743065CE4078Anthony King |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
dcterms:creator |
ripekg:author/RIPEAU35E7B3109E82806EJemma Hudson |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
dcterms:creator |
ripekg:author/RIPEAU37F54EAB5C458751Velota Sung |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
dcterms:creator |
ripekg:author/RIPEAU38C61B3201F849FAObaid Kousha |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
dcterms:creator |
ripekg:author/RIPEAU3C3F1F7F153180A4Joanna Liput |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
dcterms:creator |
ripekg:author/RIPEAU3E918AD748805C11John Sparrow |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
dcterms:creator |
ripekg:author/RIPEAU3ED8A84B3F2B6C2EKaren Martin |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
dcterms:creator |
ripekg:author/RIPEAU44DCE819E20E0006Sikander Sidiki |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
dcterms:creator |
ripekg:author/RIPEAU48AA31171AFFA663David Garway-Heath |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
dcterms:creator |
ripekg:author/RIPEAU48DE44FD42410666Josh Pilling |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
dcterms:creator |
ripekg:author/RIPEAU4AE5843248F04137Catherine Willshire |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
dcterms:creator |
ripekg:author/RIPEAU4C56B0D11E33BAE8Pankaj Agarwal |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
dcterms:creator |
ripekg:author/RIPEAU4E5CC7EC701ED200Anil Negi |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
dcterms:creator |
ripekg:author/RIPEAU4FFFB3B82B45FD28Eleni Nikita |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
dcterms:creator |
ripekg:author/RIPEAU571C47EDB9509080Graham Auger |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
dcterms:creator |
ripekg:author/RIPEAU5AE54838CA5B463CImran Masood |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
dcterms:creator |
ripekg:author/RIPEAU5BAB8A4CEDD159EFAlbina Dardzhikova |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
dcterms:creator |
ripekg:author/RIPEAU61FD524AA7278A19Giacinto Triolo |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
dcterms:creator |
ripekg:author/RIPEAU65F6B53C8B6A718ESoledad Aguilar-Munoa |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
dcterms:creator |
ripekg:author/RIPEAU683BC3917BD6DB19Amanjeet Sandhu |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
dcterms:creator |
ripekg:author/RIPEAU6920282616D1F8B4Rupert Bourne |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
dcterms:creator |
ripekg:author/RIPEAU6A4B17A5B13E1FBBGraeme Maclennan |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
dcterms:creator |
ripekg:author/RIPEAU6AB53E7019272701Tanya Karaconji |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
dcterms:creator |
ripekg:author/RIPEAU6B15643374BE9073Philip Bloom |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
dcterms:creator |
ripekg:author/RIPEAU71AF9E8A9C6CEE0DTracey Davidson |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
dcterms:creator |
ripekg:author/RIPEAU72B4D906355091D7Marta Hovan |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
dcterms:creator |
ripekg:author/RIPEAU75EAA11865B0B72DKeith Barton |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
dcterms:creator |
ripekg:author/RIPEAU7A84ACD671D49100Goncalo Almeida |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
dcterms:creator |
ripekg:author/RIPEAU7B49EE23B8F176A0Pavi Agrawal |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
dcterms:creator |
ripekg:author/RIPEAU7B4C11E2DA3F0D12Laura Crawley |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
dcterms:creator |
ripekg:author/RIPEAU7F6D656A37D556C4Gus Gazzard |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
dcterms:creator |
ripekg:author/RIPEAU8074995187A73D2DSheng Lim |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
dcterms:creator |
ripekg:author/RIPEAU81B9D31E377A6663Prodromos Kontovourikis |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
dcterms:creator |
ripekg:author/RIPEAU879B7F4F5682E77FTara Homer |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
dcterms:creator |
ripekg:author/RIPEAU888350EDEB7F480ERichard Thornton |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
dcterms:creator |
ripekg:author/RIPEAU894A261B9FEC2068Franesca Cordeiro |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
dcterms:creator |
ripekg:author/RIPEAU8BD8F042993E207FCaroline Cobb |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
dcterms:creator |
ripekg:author/RIPEAU8E3823CAB0A14628Fiona Grey |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
dcterms:creator |
ripekg:author/RIPEAU9004D478DD388D82Elizabeth Hill |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
dcterms:creator |
ripekg:author/RIPEAU90C4F6996050D1EETracey Nixon |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
dcterms:creator |
ripekg:author/RIPEAU98D0815DC583BFBBAngela Knox |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
dcterms:creator |
ripekg:author/RIPEAU9C23AD13D8CE5696Andrew Tatham |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
dcterms:creator |
ripekg:author/RIPEAU9F208A0BDFF25909Faisal Ahmed |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
dcterms:creator |
ripekg:author/RIPEAUA15D834826F8EFA3Reza Moosavi |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
dcterms:creator |
ripekg:author/RIPEAUA2C213C7F36090F7David Broadway |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
dcterms:creator |
ripekg:author/RIPEAUA2E5C0C196259148James Tildsley |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
dcterms:creator |
ripekg:author/RIPEAUA3B995B8D8DC7FD8Eduardo Normando |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
dcterms:creator |
ripekg:author/RIPEAUA5DD937650A9F27FAlistair Porteous |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
dcterms:creator |
ripekg:author/RIPEAUA7BF1966BD388EC0Amit Datta |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
dcterms:creator |
ripekg:author/RIPEAUAF408D68981BA9F8Sara Wilson |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
dcterms:creator |
ripekg:author/RIPEAUB3C516AEDBEB75B5Edward Rule |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
dcterms:creator |
ripekg:author/RIPEAUBAE7909266EAEE31Marta Toth |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
dcterms:creator |
ripekg:author/RIPEAUBBF76A208E67BA88Avinash Prabhu |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
dcterms:creator |
ripekg:author/RIPEAUBD9E70B4C4D654C2Gurjeet Jutley |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
dcterms:creator |
ripekg:author/RIPEAUBEF0ADF8E5C8630FChelvin Sng |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
dcterms:creator |
ripekg:author/RIPEAUC2FD9A60A28F2768Mary Freeman |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
dcterms:creator |
ripekg:author/RIPEAUC4364B9302EDD207Alisdair Fern |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
dcterms:creator |
ripekg:author/RIPEAUC555AECD22588109Richard Imonikhe |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
dcterms:creator |
ripekg:author/RIPEAUDD3F81F59E9225BFAshleigh Kernohan |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
dcterms:creator |
ripekg:author/RIPEAUDFE36B17AEF46D78Leon Au |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
dcterms:creator |
ripekg:author/RIPEAUE2E1169912CDAF36Dimitrios Bessinis |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
dcterms:creator |
ripekg:author/RIPEAUE5425DD36F9C6FD8Clare Stemp |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
dcterms:creator |
ripekg:author/RIPEAUE71267433388B35BAhmed Elkarmouty |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
dcterms:creator |
ripekg:author/RIPEAUEB35CFD7DD9CBD46Luke Membrey |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
dcterms:creator |
ripekg:author/RIPEAUED0695BBEB618B56Anastasios Sepetis |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
dcterms:creator |
ripekg:author/RIPEAUEDC39999AA6C3452Brett Drury |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
dcterms:creator |
ripekg:author/RIPEAUF27232367D0E5E66Nicholas Wride |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
dcterms:creator |
ripekg:author/RIPEAUF68DECB7FF1A5D97John Norrie |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
dcterms:creator |
ripekg:author/RIPEAUF7AACCCDB19F8FC2Andrew Mcnaught |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
dcterms:creator |
ripekg:author/RIPEAUF8A17C2B7D446DE7Cecelia Fenerty |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
dcterms:creator |
ripekg:author/RIPEAUFC2CFF6F528028EBSally Ameen |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
dcterms:creator |
ripekg:author/RIPEAUFCCD6890E95DDB1CGnanapragasam Nithyanandarajah |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
dcterms:creator |
ripekg:author/RIPEAUFF1A985903EF3B26Nick Strouthidis |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
dcterms:title |
Evaluating Primary Treatment for People with Advanced Glaucoma |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEW021D56FAB4223B40Will the PRESERFLO TM MicroShunt impact the future of trabeculectomy practice? A UK and Éire Glaucoma Society National Survey. A UK and Éire Glaucoma Society National Survey |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEW06DD376CBFD4B7E7Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L) |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEW08D1CF06B2ADFAB9Theoretical and empirical dimensions of the Aberdeen glaucoma questionnaire: a cross sectional survey and principal component analysis |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEW0A8AFEBB076CE5CATrabeculectomy in the 21st century: a multicenter analysis |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEW21694A64E03E3C41Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEW2694D4C6794BC995TAGS Study Group. Primary trabeculectomy for advanced glaucoma: pragmatic multicentre randomised controlled trial (TAGS) |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEW28E482FA6577B20BPrimary trabeculectomy versus primary glaucoma eye drops for newly diagnosed advanced glaucoma: TAGS RCT |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEW2948560DFF14F7BBDevelopment of the 25-item National Eye Institute Visual Function Questionnaire |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEW2948D1A74FE2238AStructural en face OCT showed a larger lesion area (C). The circular and punctate lesions showed atrophy of the retina (D, asterisks) and discontinuity in the retinal pigment epithelium layer with hyperreflective foci (E, arrow) and overlying vitritis on OCT. Treatment with systemic antimicrobials and glucocorticoids abated the retinitis by 1 month |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEW2DD2629A9372F005Treatment of Advanced Glaucoma Study: a multicentre randomised controlled trial comparing primary medical treatment with primary trabeculectomy for people with newly diagnosed advanced glaucomastudy protocol |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEW356E807056DBEC96Challenges in evaluating surgical innovation |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEW443FE75183856E9EClinical Decisions in Glaucoma |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEW455A221EB591768ESurvival of visual function in patients with advanced glaucoma after standard guarded trabeculectomy with MMC |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEW52D2D11DDF6626D0Glaucoma: diagnosis and management |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEW5B554ED3A83D11B4Glaucoma blindness at the end of life |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEW5CCC85BD030BDBC4Terminology and Guidelines for Glaucoma |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEW62A6CFD472BE5904Developing a preference-based Glaucoma Utility Index using a discrete choice experiment |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEW62A6CFD472BE5904Developing a preference-based glaucoma utility index using a discrete choice experiment |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEW683473E1A24E770EAttitudes of consultant ophthalmologists in the UK to initial management of glaucoma patients presenting with severe visual field loss: a national survey |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEW77DE2B9100BEC7ECCertificate of vision impairment: explanatory notes for consultant ophthalmologists and hospital eye clinic staff in England |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEW84C9FBF7999ACCF4Ab-externo MicroShunt versus trabeculectomy in primary open-angle glaucoma: one-year results from a 2-year randomized, multicenter study |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEW86AA573A23F303C2The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEW8934B08FB1809B26Disease severity in newly diagnosed glaucoma patients with visual field loss: trends from more than a decade of data |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEW946F9D114F4C691AThe association between medication adherence and visual field progression in the Collaborative Initial Glaucoma Treatment Study |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEWA4058890EECA9CA6Survival analysis for AdVerse events with VarYing follow-up times (SAVVY): rationale and statistical concept of a meta-analytic study |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEWA56E1F6431593DFBTreatment outcomes in the primary Tube Versus Trabeculectomy Study after 3 years of follow-up |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEWAEDAD37209BACB08Two-year visual field outcomes of the Treatment of Advanced Glaucoma Study (TAGS) |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEWAF726324EFFB2462Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEWB1E0E8DB419CFC5ATarget IOP Workshop Participants. Canadian perspectives in glaucoma management: setting target intraocular pressure range |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEWBA28A5D42FF215B2Appropriate statistical methods for analysing partially nested randomised controlled trials with continuous outcomes: a simulation study |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEWDB05167C133E8C5BBaseline characteristics of participants in the Treatment of Advanced Glaucoma Study (TAGS): a multicentre randomised controlled trial |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEWDF5567F2AE2F38FCExploring patients' expectations and preferences of glaucoma surgery outcomes to facilitate healthcare delivery and inform future glaucoma research |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEWE1C7E0D114678845Patient-reported outcome measures should not be the primary outcome in glaucoma clinical trials of disease modification |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEWEB56EC6A6CAB3C0COutcome of trabeculectomy with mitomycin C in patients with advanced glaucoma |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEWEDBE0F7939E12430Are patient self-reported outcome measures sensitive enough to be used as end points in clinical trials? Evidence from the United Kingdom Glaucoma Treatment Study |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEWEE822CBA9974B538Primary trabeculectomy for advanced glaucoma: pragmatic multicentre randomised controlled trial (TAGS) |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEWEEC2952604612B34Primary open angle glaucoma: Preferred Practice Patterns |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEWEED3A7F33C4B86B8The effect of socioeconomic deprivation on severity of glaucoma at presentation |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEWF2A299B28CE74378The Health Utilities Index (HUI) system for assessing health-related quality of life in clinical studies |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEWFFFA0EEF57B5BD13Medical versus surgical interventions for open angle glaucoma |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
rdf:type |
node1 |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
rdf:type |
http://purl.org/spar/fabio/Work |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
rdf:type |
rdfs:Resource |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
rdf:type |
owl:Thing |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
rdf:type |
prov:Entity |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
rdf:type |
ripe:WorkWork |
ripekg:work/10.1016%2Fj.ophtha.2024.01.007Evaluating Primary Treatment for People with Advanced Glaucoma |
owl:sameAs |
https://semopenalex.org/work/W4390685927 |